CR9486A - Composiciones y metodos para el diagnostico y tratamiento del tumor - Google Patents

Composiciones y metodos para el diagnostico y tratamiento del tumor

Info

Publication number
CR9486A
CR9486A CR9486A CR9486A CR9486A CR 9486 A CR9486 A CR 9486A CR 9486 A CR9486 A CR 9486A CR 9486 A CR9486 A CR 9486A CR 9486 A CR9486 A CR 9486A
Authority
CR
Costa Rica
Prior art keywords
compositions
diagnosis
methods
tumor treatment
tumor
Prior art date
Application number
CR9486A
Other languages
English (en)
Spanish (es)
Inventor
Dowd Patrick
Polakis Paul
Smith Victoria
Spencer Susan
Wu Thomas
Zhang Zemin
Frantz Gretchen
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/102,501 external-priority patent/US20050272120A1/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of CR9486A publication Critical patent/CR9486A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CR9486A 2005-04-08 2007-10-30 Composiciones y metodos para el diagnostico y tratamiento del tumor CR9486A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/102,501 US20050272120A1 (en) 2001-06-20 2005-04-08 Compositions and methods for the diagnosis and treatment of tumor

Publications (1)

Publication Number Publication Date
CR9486A true CR9486A (es) 2008-02-20

Family

ID=38667206

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9486A CR9486A (es) 2005-04-08 2007-10-30 Composiciones y metodos para el diagnostico y tratamiento del tumor

Country Status (14)

Country Link
EP (1) EP1871886A2 (no)
JP (1) JP2008535498A (no)
KR (1) KR20080003405A (no)
CN (1) CN101208431A (no)
AU (1) AU2006235436A1 (no)
BR (1) BRPI0609729A2 (no)
CA (1) CA2604377A1 (no)
CR (1) CR9486A (no)
IL (1) IL185900A0 (no)
MA (1) MA29587B1 (no)
MX (1) MX2007012216A (no)
NO (1) NO20075698L (no)
RU (1) RU2007141407A (no)
ZA (1) ZA200707967B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3002297B1 (en) * 2009-11-30 2020-04-08 F. Hoffmann-La Roche AG Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211)
MX2014013806A (es) * 2012-05-14 2014-11-26 Genentech Inc Composiciones y metodos para el diagnostico y tratamiento de tumores.
WO2020246584A1 (ja) * 2019-06-06 2020-12-10 デンカ株式会社 ペプチド核酸を基盤としたアジュバント

Also Published As

Publication number Publication date
MA29587B1 (fr) 2008-07-01
CN101208431A (zh) 2008-06-25
IL185900A0 (en) 2008-01-06
AU2006235436A2 (en) 2006-10-19
NO20075698L (no) 2008-01-07
AU2006235436A1 (en) 2006-10-19
MX2007012216A (es) 2007-12-06
KR20080003405A (ko) 2008-01-07
EP1871886A2 (en) 2008-01-02
JP2008535498A (ja) 2008-09-04
ZA200707967B (en) 2008-11-26
RU2007141407A (ru) 2009-05-20
BRPI0609729A2 (pt) 2010-04-20
CA2604377A1 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
CR11216A (es) Anticuerpos anti-cd79b e inmmunoconjugados y metodos de uso de los mismos
ECSP109940A (es) Anticuerpos anti-cd79b e inmunoconjugados humanizados y métodos de uso
NL300936I2 (nl) Semaglutide
CR20130455A (es) Composiciones para el tratamiento de tumores
EA200970737A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
EA201170252A1 (ru) Амидофеноксиндазолы в качестве ингибиторов c-мет
ECSP088508A (es) Antagonistas de neuropilina
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
ECSP078013A (es) Inhibidores heterocíclicos de mek y métodos de uso de ellos
EA201000888A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и 2-фенилциклогексан-1,3,5-трионы в качестве гербицидов
CL2009000545A1 (es) Uso de un antagonista de c-met y un antagonista de her para el tratamiento de cancer.
NI201200080A (es) Antagonistas de il-17a
CR8986A (es) Isoxazoles sustituidos como fungicidas
EA201171367A1 (ru) Винилиндазолильные соединения
CR8919A (es) Analogos de tetrapeptidos
GT200600035A (es) Aminopiridinas como inhibidores de beta-secretasa
CL2009000260A1 (es) Antagonista de pcsk9 que comprende un dominio cdr3 de la region variable de la cadena liviana y pesada, el cual inhibe la captacion celular del ldl, composicion farmaceutica que comprende dicho antagonista, uso de este, secuencia nucleotidica que codifica el antagonista, vector y celula huesped que la comprende.
CO6321189A2 (es) Compuestos de tiazol y oxazol de bencen-sulfonamida
HN2005029978A (es) Formulaciones
EA200901074A1 (ru) Лечение метастатической стадии рака предстательной железы дегареликсом
CL2008001373A1 (es) Compuestos derivados de fenilamino-benceno sustituidos; metodo de preparacion; composicion farmaceutica; kit farmceuticos; y uso de dichos compuestos en el tratamiento del cancer.
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
BRPI0712607A8 (pt) métodos de tratamento de acidente vascular cerebral

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)